Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Expression profiles of acute myeloid leukemia patient samples
PubMed Similar studies Analyze with GEO2R
Abnormal Expression Changes in AML
Acute myeloid leukemia
PubMed Similar studies GEO Profiles Analyze DataSet
Acute myeloid leukemia study
Adult acute myeloid leukemia: bone marrow and peripheral blood expression profiles (SHDJ)
Adult acute myeloid leukemia: bone marrow and peripheral blood expression profiles (SHCO)
Gene expression profiling identifies distinct subclasses of core binding factor acute myeloid leukemia.
de novo childhood AML patients and FLT3 mutations.
Mutant WT1 is Associated with DNA Hypermethylation of PRC2 Targets in AML and Responds to EZH2 Inhibition
PubMed Full text in PMC Similar studies
Classification of pediatric acute myeloid leukemia based on miRNA expression profiles
PubMed Full text in PMC Similar studies Analyze with GEO2R
Gene expression profiles of mono- and biallelic CEBPA mutations in cytogenetically normal AML
Gene expression profiling of CEBPA double-, single-mutant and CEBPA wild type AML
Gene expression profiling of CEBPA double and single mutant and CEBPA wild type AML.
Acute myeloid leukemia with CEBPA mutations [AMLSG cohort]: mononuclear cells
Routine use of microarray-based gene expression profiling to identify patients with low cytogenetic risk acute myeloid leukemia: accurate results can be obtained even with suboptimal samples
Routine use of microarray-based gene expression profiling to identify patients with low cytogenetic risk acute myeloid leukemia: accurate results can be obtained even with suboptimal samples. (test samples)
Routine use of microarray-based gene expression profiling to identify patients with low cytogenetic risk acute myeloid leukemia: accurate results can be obtained even with suboptimal samples (training samples)
Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML
High VEGFC expression is associated with unique gene expression profiles and predicts adverse prognosis in pediatric and adult acute myeloid leukemia.
Acute myeloid leukemia samples of samples =< 60yrs on HG-U133 plus 2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on